The use of mycophenolate mofetil in the treatment of refractory chronic graft versus host disease.

被引：0
|
作者：
Pallotta, RS
Barbosa, JAL
Macedo, MCMA
Saboya, R
Silva, RL
Jamra, M
Chamone, DAF
Dulley, FL
机构：
[1] Hemoctr Sao Paulo, Fundacao Prosangue, BMT Program, Sao Paulo, Brazil
[2] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4489
引用
收藏
页码：346B / 346B
页数：1
相关论文
共 50 条
  • [21] Etretinate: A novel agent for the treatment of refractory sclerodermatous chronic graft versus host disease.
    Marcellus, DC
    Altomonte, V
    Farmer, ER
    Horn, TD
    Freemer, C
    Grant, J
    Vogelsang, GB
    BLOOD, 1995, 86 (10) : 1579 - 1579
  • [22] A pilot study of mycophenolate mofetil for the prophylaxis and treatment of graft-versus-host disease
    Luo, Chengwei
    Du, Xin
    Weng, Jianyu
    Guo, Rong
    Lu, Zesheng
    BLOOD, 2007, 110 (11) : 319B - 319B
  • [23] Mycophenolate mofetil as rescue therapy for high-risk steroid-refractory chronic graft versus host-disease
    Carpenter, PA
    Woolfrey, AE
    Sievers, EL
    Sanders, JE
    PEDIATRIC RESEARCH, 2003, 53 (04) : 275A - 275A
  • [24] The use of thalidomide in chronic refractory graft versus host disease
    van de Poel, MHW
    Pasman, PC
    Schouten, HC
    NETHERLANDS JOURNAL OF MEDICINE, 2001, 59 (02): : 45 - 49
  • [25] Hydroxychloroquine for the treatment of chronic graft-versus-host disease.
    Gilman, A
    Morris, C
    Mogul, M
    Mazumder, A
    Lee, CK
    Gingrich, R
    Goldman, F
    Trigg, M
    BLOOD, 1996, 88 (10) : 2421 - 2421
  • [26] Primary treatment inconsistencies in chronic graft versus host disease.
    Bensen-Kennedy, DM
    Hallick, J
    Jacobsohn, DA
    Anders, V
    Vogelsang, GB
    BLOOD, 2002, 100 (11) : 847A - 847A
  • [27] COMPARISON OF SIROLIMUS AND MYCOPHENOLATE MOFETIL AS SALVAGE TREATMENT FOR ACUTE GRAFT-VERSUS-HOST DISEASE
    Nishihori, T.
    Pidala, J.
    Kim, J.
    Tomblyn, M.
    Anasetti, C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S368 - S368
  • [28] Mycophenolate mofetil treatment of glomerular disease.
    Briggs, WA
    Choi, M
    Scheel, PJ
    Onuchic, LF
    Mathew, S
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A0396 - A0396
  • [29] Baricitinib/mycophenolate mofetil/prednisoloneLack of efficacy in chronic graft versus host disease and off label use: 2 case reports
    Reactions Weekly, 2022, 1898 (1) : 110 - 110
  • [30] Maximizing the Benefits of Mycophenolate Mofetil as Graft-versus-Host Disease Prophylaxis
    Hamilton, Betty Ky
    Kalaycio, Matt
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (11) : 1869 - 1870
12345